Biomarkers and Surrogate Endpoints in Renal Transplantation: Present Status and Considerations for Clinical Trial DesignPeter A. Lachenbruch, Robert B. Colvin, Amy S. Rosenberg et al.|American Journal of Transplantation|2004Cited by 73
Combating viral contaminants in CHO cells by engineering innate immunityAustin W.T. Chiang, Nathan E. Lewis, Shangzhong Li et al.|Scientific Reports|2019Cited by 23